+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Artificial Pancreas Devices Systems Market By Device Type: Global Opportunity Analysis and Industry Forecast, 2024-2033

  • PDF Icon

    Report

  • 280 Pages
  • July 2024
  • Region: Global
  • Allied Market Research
  • ID: 5994254
Description Jump to:
The artificial pancreas devices systems market was valued at $0.4 billion in 2023, and is projected to reach $0.8 billion by 2033, growing at a CAGR of 8.8% from 2024 to 2033.

Artificial pancreas device is a medical device that mimics the glucose-regulating function of a healthy pancreas, aiming to maintain optimal blood sugar levels. This medical technology is primarily designed to monitor and regulate blood glucose levels in individuals suffering from diabetes, particularly those with type 1 diabetes. These devices aim to restore lost functions, enhance human capabilities, and improve overall quality of life.

The growth of the artificial pancreas devices systems market is majorly driven by alarming increase in global prevalence of diabetes, particularly type 1 diabetes and rise in awareness among patients and healthcare providers about the benefits of artificial pancreas systems. According to the 2021 key findings of IDF Diabetes Atlas 10th edition, approximately 537 million adults are suffering diabetes. This number is estimated to reach 643 million by 2030 and 783 million by 2045. Around 6.7 million deaths were reported due to diabetes in 2021. Moreover, increase in healthcare expenditure, particularly in emerging economies, allows more patients to access advanced diabetes management technologies. As per the same source, diabetes was responsible for at least $966 billion dollars in health expenditure in 2021. Furthermore, the integration of artificial pancreas devices systems with digital health platforms and smartphone applications enhances patient engagement and allows for better remote monitoring and management, which acts as the key driving force of the market. However, high cost associated with the artificial pancreas devices systems restrains the growth of the market. Moreover, lack of appropriate health facilities to meet population needs in most countries and limited access act as the key deterrent factors of the market. On the contrary, continuous improvements in sensor technology, insulin delivery systems, and control algorithms enhance the performance and reliability of artificial pancreas systems, which are expected to offer remunerative opportunities for the expansion of the global market during the forecast period. In addition, increase in initiatives aimed at improving diabetes care and management are providing incentives for the adoption of artificial pancreas systems. For instance, the World Health Organization launched an initiative in April 2021, WHO Global Diabetes Compact. The initiative aims to reduce the risk of diabetes and ensure that diabetic individuals have access to affordable and quality treatment and care.

The artificial pancreas devices systems industry is segmented into device type, end user, and region. By device type, the market is divided into threshold suspend device systems, control-to-range (CTR) systems, and control-to-target (CTT) systems. On the basis of end user, it is divided into hospitals, clinics, homecare. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By device type, the threshold suspend device systems segment dominated the market, in terms of share, in 2023.

Depending on end user, the homecare segment captured the largest share in 2023.

Region wise, North America holds a dominant position in the market in 2023.

Competition Analysis

Competitive analysis and profiles of the major players in the global artificial pancreas devices systems market include Medtronic plc, Bigfoot Biomedical, Inc., Johnson & Johnson, Tandem Diabetes Care, Inc., Pancreum, Inc, TypeZero Technologies, LLC, Beta Bionics, Inc, Insulate Corporation, Diabeloop, and Inreda Diabetic. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data

Key Market Segments

By Device Type

  • Threshold Suspend Device Systems
  • Control-To-Range (CTR) Systems
  • Control-To-Target (CTT) Systems

By End User

  • Hospitals
  • Clinics
  • Homecare

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players

  • Medtronic plc
  • Bigfoot Biomedical, Inc.
  • Johnson & Johnson
  • Tandem Diabetes Care, Inc.
  • Pancreum, Inc
  • TypeZero Technologies, LLC
  • Beta Bionics, Inc
  • Insulate Corporation
  • Diabeloop
  • Inreda Diabetic

 

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY DEVICE TYPE
4.1. Market Overview
4.1.1 Market Size and Forecast, By Device Type
4.2. Threshold Suspend Device Systems
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Control-To-Range (CTR) Systems
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Control-To-Target (CTT) Systems
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
CHAPTER 5: ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY END USER
5.1. Market Overview
5.1.1 Market Size and Forecast, By End User
5.2. Hospitals
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Clinics
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Homecare
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
CHAPTER 6: ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY REGION
6.1. Market Overview
6.1.1 Market Size and Forecast, By Region
6.2. North America
6.2.1. Key Market Trends and Opportunities
6.2.2. Market Size and Forecast, By Device Type
6.2.3. Market Size and Forecast, By End User
6.2.4. Market Size and Forecast, By Country
6.2.5. U.S. Artificial Pancreas Devices Systems Market
6.2.5.1. Market Size and Forecast, By Device Type
6.2.5.2. Market Size and Forecast, By End User
6.2.6. Canada Artificial Pancreas Devices Systems Market
6.2.6.1. Market Size and Forecast, By Device Type
6.2.6.2. Market Size and Forecast, By End User
6.2.7. Mexico Artificial Pancreas Devices Systems Market
6.2.7.1. Market Size and Forecast, By Device Type
6.2.7.2. Market Size and Forecast, By End User
6.3. Europe
6.3.1. Key Market Trends and Opportunities
6.3.2. Market Size and Forecast, By Device Type
6.3.3. Market Size and Forecast, By End User
6.3.4. Market Size and Forecast, By Country
6.3.5. Germany Artificial Pancreas Devices Systems Market
6.3.5.1. Market Size and Forecast, By Device Type
6.3.5.2. Market Size and Forecast, By End User
6.3.6. France Artificial Pancreas Devices Systems Market
6.3.6.1. Market Size and Forecast, By Device Type
6.3.6.2. Market Size and Forecast, By End User
6.3.7. UK Artificial Pancreas Devices Systems Market
6.3.7.1. Market Size and Forecast, By Device Type
6.3.7.2. Market Size and Forecast, By End User
6.3.8. Italy Artificial Pancreas Devices Systems Market
6.3.8.1. Market Size and Forecast, By Device Type
6.3.8.2. Market Size and Forecast, By End User
6.3.9. Spain Artificial Pancreas Devices Systems Market
6.3.9.1. Market Size and Forecast, By Device Type
6.3.9.2. Market Size and Forecast, By End User
6.3.10. Rest Of Europe Artificial Pancreas Devices Systems Market
6.3.10.1. Market Size and Forecast, By Device Type
6.3.10.2. Market Size and Forecast, By End User
6.4. Asia-Pacific
6.4.1. Key Market Trends and Opportunities
6.4.2. Market Size and Forecast, By Device Type
6.4.3. Market Size and Forecast, By End User
6.4.4. Market Size and Forecast, By Country
6.4.5. Japan Artificial Pancreas Devices Systems Market
6.4.5.1. Market Size and Forecast, By Device Type
6.4.5.2. Market Size and Forecast, By End User
6.4.6. China Artificial Pancreas Devices Systems Market
6.4.6.1. Market Size and Forecast, By Device Type
6.4.6.2. Market Size and Forecast, By End User
6.4.7. Australia Artificial Pancreas Devices Systems Market
6.4.7.1. Market Size and Forecast, By Device Type
6.4.7.2. Market Size and Forecast, By End User
6.4.8. India Artificial Pancreas Devices Systems Market
6.4.8.1. Market Size and Forecast, By Device Type
6.4.8.2. Market Size and Forecast, By End User
6.4.9. South Korea Artificial Pancreas Devices Systems Market
6.4.9.1. Market Size and Forecast, By Device Type
6.4.9.2. Market Size and Forecast, By End User
6.4.10. Rest of Asia-Pacific Artificial Pancreas Devices Systems Market
6.4.10.1. Market Size and Forecast, By Device Type
6.4.10.2. Market Size and Forecast, By End User
6.5. LAMEA
6.5.1. Key Market Trends and Opportunities
6.5.2. Market Size and Forecast, By Device Type
6.5.3. Market Size and Forecast, By End User
6.5.4. Market Size and Forecast, By Country
6.5.5. Brazil Artificial Pancreas Devices Systems Market
6.5.5.1. Market Size and Forecast, By Device Type
6.5.5.2. Market Size and Forecast, By End User
6.5.6. Saudi Arabia Artificial Pancreas Devices Systems Market
6.5.6.1. Market Size and Forecast, By Device Type
6.5.6.2. Market Size and Forecast, By End User
6.5.7. South Africa Artificial Pancreas Devices Systems Market
6.5.7.1. Market Size and Forecast, By Device Type
6.5.7.2. Market Size and Forecast, By End User
6.5.8. Rest of LAMEA Artificial Pancreas Devices Systems Market
6.5.8.1. Market Size and Forecast, By Device Type
6.5.8.2. Market Size and Forecast, By End User
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top Winning Strategies
7.3. Product Mapping Of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top Player Positioning, 2023
CHAPTER 8: COMPANY PROFILES
8.1. Medtronic Plc
8.1.1. Company Overview
8.1.2. Key Executives
8.1.3. Company Snapshot
8.1.4. Operating Business Segments
8.1.5. Product Portfolio
8.1.6. Business Performance
8.1.7. Key Strategic Moves and Developments
8.2. Bigfoot Biomedical, Inc.
8.2.1. Company Overview
8.2.2. Key Executives
8.2.3. Company Snapshot
8.2.4. Operating Business Segments
8.2.5. Product Portfolio
8.2.6. Business Performance
8.2.7. Key Strategic Moves and Developments
8.3. Johnson And Johnson
8.3.1. Company Overview
8.3.2. Key Executives
8.3.3. Company Snapshot
8.3.4. Operating Business Segments
8.3.5. Product Portfolio
8.3.6. Business Performance
8.3.7. Key Strategic Moves and Developments
8.4. Tandem Diabetes Care, Inc.
8.4.1. Company Overview
8.4.2. Key Executives
8.4.3. Company Snapshot
8.4.4. Operating Business Segments
8.4.5. Product Portfolio
8.4.6. Business Performance
8.4.7. Key Strategic Moves and Developments
8.5. Pancreum, Inc
8.5.1. Company Overview
8.5.2. Key Executives
8.5.3. Company Snapshot
8.5.4. Operating Business Segments
8.5.5. Product Portfolio
8.5.6. Business Performance
8.5.7. Key Strategic Moves and Developments
8.6. TypeZero Technologies, LLC
8.6.1. Company Overview
8.6.2. Key Executives
8.6.3. Company Snapshot
8.6.4. Operating Business Segments
8.6.5. Product Portfolio
8.6.6. Business Performance
8.6.7. Key Strategic Moves and Developments
8.7. Beta Bionics, Inc
8.7.1. Company Overview
8.7.2. Key Executives
8.7.3. Company Snapshot
8.7.4. Operating Business Segments
8.7.5. Product Portfolio
8.7.6. Business Performance
8.7.7. Key Strategic Moves and Developments
8.8. Insulate Corporation
8.8.1. Company Overview
8.8.2. Key Executives
8.8.3. Company Snapshot
8.8.4. Operating Business Segments
8.8.5. Product Portfolio
8.8.6. Business Performance
8.8.7. Key Strategic Moves and Developments
8.9. Diabeloop
8.9.1. Company Overview
8.9.2. Key Executives
8.9.3. Company Snapshot
8.9.4. Operating Business Segments
8.9.5. Product Portfolio
8.9.6. Business Performance
8.9.7. Key Strategic Moves and Developments
8.10. Inreda Diabetic
8.10.1. Company Overview
8.10.2. Key Executives
8.10.3. Company Snapshot
8.10.4. Operating Business Segments
8.10.5. Product Portfolio
8.10.6. Business Performance
8.10.7. Key Strategic Moves and Developments
LIST OF TABLES
TABLE 1. GLOBAL ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY DEVICE TYPE, 2024 - 2033 ($BILLION)
TABLE 2. ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET FOR THRESHOLD SUSPEND DEVICE SYSTEMS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 3. ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET FOR CONTROL-TO-RANGE (CTR) SYSTEMS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 4. ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET FOR CONTROL-TO-TARGET (CTT) SYSTEMS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 5. GLOBAL ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 6. ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET FOR HOSPITALS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 7. ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET FOR CLINICS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 8. ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET FOR HOMECARE, BY REGION, 2024 - 2033 ($BILLION)
TABLE 9. ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY REGION, 2024 - 2033 ($BILLION)
TABLE 10. NORTH AMERICA ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 11. NORTH AMERICA ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY DEVICE TYPE, 2024 - 2033 ($BILLION)
TABLE 12. NORTH AMERICA ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 13. U.S. ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY DEVICE TYPE, 2024 - 2033 ($BILLION)
TABLE 14. U.S. ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 15. CANADA ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY DEVICE TYPE, 2024 - 2033 ($BILLION)
TABLE 16. CANADA ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 17. MEXICO ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY DEVICE TYPE, 2024 - 2033 ($BILLION)
TABLE 18. MEXICO ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 19. EUROPE ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 20. EUROPE ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY DEVICE TYPE, 2024 - 2033 ($BILLION)
TABLE 21. EUROPE ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 22. GERMANY ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY DEVICE TYPE, 2024 - 2033 ($BILLION)
TABLE 23. GERMANY ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 24. FRANCE ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY DEVICE TYPE, 2024 - 2033 ($BILLION)
TABLE 25. FRANCE ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 26. UK ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY DEVICE TYPE, 2024 - 2033 ($BILLION)
TABLE 27. UK ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 28. ITALY ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY DEVICE TYPE, 2024 - 2033 ($BILLION)
TABLE 29. ITALY ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 30. SPAIN ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY DEVICE TYPE, 2024 - 2033 ($BILLION)
TABLE 31. SPAIN ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 32. REST OF EUROPE ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY DEVICE TYPE, 2024 - 2033 ($BILLION)
TABLE 33. REST OF EUROPE ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 34. ASIA-PACIFIC ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 35. ASIA-PACIFIC ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY DEVICE TYPE, 2024 - 2033 ($BILLION)
TABLE 36. ASIA-PACIFIC ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 37. JAPAN ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY DEVICE TYPE, 2024 - 2033 ($BILLION)
TABLE 38. JAPAN ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 39. CHINA ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY DEVICE TYPE, 2024 - 2033 ($BILLION)
TABLE 40. CHINA ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 41. AUSTRALIA ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY DEVICE TYPE, 2024 - 2033 ($BILLION)
TABLE 42. AUSTRALIA ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 43. INDIA ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY DEVICE TYPE, 2024 - 2033 ($BILLION)
TABLE 44. INDIA ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 45. SOUTH KOREA ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY DEVICE TYPE, 2024 - 2033 ($BILLION)
TABLE 46. SOUTH KOREA ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 47. REST OF ASIA-PACIFIC ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY DEVICE TYPE, 2024 - 2033 ($BILLION)
TABLE 48. REST OF ASIA-PACIFIC ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 49. LAMEA ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 50. LAMEA ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY DEVICE TYPE, 2024 - 2033 ($BILLION)
TABLE 51. LAMEA ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 52. BRAZIL ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY DEVICE TYPE, 2024 - 2033 ($BILLION)
TABLE 53. BRAZIL ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 54. SAUDI ARABIA ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY DEVICE TYPE, 2024 - 2033 ($BILLION)
TABLE 55. SAUDI ARABIA ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 56. SOUTH AFRICA ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY DEVICE TYPE, 2024 - 2033 ($BILLION)
TABLE 57. SOUTH AFRICA ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 58. REST OF LAMEA ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY DEVICE TYPE, 2024 - 2033 ($BILLION)
TABLE 59. REST OF LAMEA ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 60. MEDTRONIC PLC: KEY EXECUTIVES
TABLE 61. MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 62. MEDTRONIC PLC: OPERATING SEGMENTS
TABLE 63. MEDTRONIC PLC: PRODUCT PORTFOLIO
TABLE 64. MEDTRONIC PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 65. BIGFOOT BIOMEDICAL, INC.: KEY EXECUTIVES
TABLE 66. BIGFOOT BIOMEDICAL, INC.: COMPANY SNAPSHOT
TABLE 67. BIGFOOT BIOMEDICAL, INC.: OPERATING SEGMENTS
TABLE 68. BIGFOOT BIOMEDICAL, INC.: PRODUCT PORTFOLIO
TABLE 69. BIGFOOT BIOMEDICAL, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 70. JOHNSON AND JOHNSON: KEY EXECUTIVES
TABLE 71. JOHNSON AND JOHNSON: COMPANY SNAPSHOT
TABLE 72. JOHNSON AND JOHNSON: OPERATING SEGMENTS
TABLE 73. JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
TABLE 74. JOHNSON AND JOHNSON: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 75. TANDEM DIABETES CARE, INC.: KEY EXECUTIVES
TABLE 76. TANDEM DIABETES CARE, INC.: COMPANY SNAPSHOT
TABLE 77. TANDEM DIABETES CARE, INC.: OPERATING SEGMENTS
TABLE 78. TANDEM DIABETES CARE, INC.: PRODUCT PORTFOLIO
TABLE 79. TANDEM DIABETES CARE, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 80. PANCREUM, INC: KEY EXECUTIVES
TABLE 81. PANCREUM, INC: COMPANY SNAPSHOT
TABLE 82. PANCREUM, INC: OPERATING SEGMENTS
TABLE 83. PANCREUM, INC: PRODUCT PORTFOLIO
TABLE 84. PANCREUM, INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 85. TYPEZERO TECHNOLOGIES, LLC: KEY EXECUTIVES
TABLE 86. TYPEZERO TECHNOLOGIES, LLC: COMPANY SNAPSHOT
TABLE 87. TYPEZERO TECHNOLOGIES, LLC: OPERATING SEGMENTS
TABLE 88. TYPEZERO TECHNOLOGIES, LLC: PRODUCT PORTFOLIO
TABLE 89. TYPEZERO TECHNOLOGIES, LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 90. BETA BIONICS, INC: KEY EXECUTIVES
TABLE 91. BETA BIONICS, INC: COMPANY SNAPSHOT
TABLE 92. BETA BIONICS, INC: OPERATING SEGMENTS
TABLE 93. BETA BIONICS, INC: PRODUCT PORTFOLIO
TABLE 94. BETA BIONICS, INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 95. INSULATE CORPORATION: KEY EXECUTIVES
TABLE 96. INSULATE CORPORATION: COMPANY SNAPSHOT
TABLE 97. INSULATE CORPORATION: OPERATING SEGMENTS
TABLE 98. INSULATE CORPORATION: PRODUCT PORTFOLIO
TABLE 99. INSULATE CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 100. DIABELOOP: KEY EXECUTIVES
TABLE 101. DIABELOOP: COMPANY SNAPSHOT
TABLE 102. DIABELOOP: OPERATING SEGMENTS
TABLE 103. DIABELOOP: PRODUCT PORTFOLIO
TABLE 104. DIABELOOP: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 105. INREDA DIABETIC: KEY EXECUTIVES
TABLE 106. INREDA DIABETIC: COMPANY SNAPSHOT
TABLE 107. INREDA DIABETIC: OPERATING SEGMENTS
TABLE 108. INREDA DIABETIC: PRODUCT PORTFOLIO
TABLE 109. INREDA DIABETIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 1. GLOBAL ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, 2024 - 2033
FIGURE 2. SEGMENTATION OF ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, 2024 - 2033
FIGURE 3. TOP INVESTMENT POCKET IN ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET
FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
FIGURE 7. LOW THREAT OF SUBSTITUTION
FIGURE 8. HIGH COMPETITIVE RIVALRY
FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET
FIGURE 10. GLOBAL ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET SEGMENTATION, BY DEVICE TYPE
FIGURE 11. ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET FOR THRESHOLD SUSPEND DEVICE SYSTEMS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 12. ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET FOR CONTROL-TO-RANGE (CTR) SYSTEMS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 13. ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET FOR CONTROL-TO-TARGET (CTT) SYSTEMS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 14. GLOBAL ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET SEGMENTATION, BY END USER
FIGURE 15. ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET FOR HOSPITALS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 16. ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET FOR CLINICS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 17. ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET FOR HOMECARE, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 18. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
FIGURE 19. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
FIGURE 20. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
FIGURE 21. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 22. COMPETITIVE DASHBOARD
FIGURE 23. COMPETITIVE HEATMAP: ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET
FIGURE 24. TOP PLAYER POSITIONING, 2023
FIGURE 25. MEDTRONIC PLC: NET SALES, 2021-2023 ($BILLION)
FIGURE 26. MEDTRONIC PLC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 27. MEDTRONIC PLC: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 28. BIGFOOT BIOMEDICAL, INC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 29. BIGFOOT BIOMEDICAL, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 30. BIGFOOT BIOMEDICAL, INC.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 31. JOHNSON AND JOHNSON: NET SALES, 2021-2023 ($BILLION)
FIGURE 32. JOHNSON AND JOHNSON: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 33. JOHNSON AND JOHNSON: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 34. TANDEM DIABETES CARE, INC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 35. TANDEM DIABETES CARE, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 36. TANDEM DIABETES CARE, INC.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 37. PANCREUM, INC: NET SALES, 2021-2023 ($BILLION)
FIGURE 38. PANCREUM, INC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 39. PANCREUM, INC: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 40. TYPEZERO TECHNOLOGIES, LLC: NET SALES, 2021-2023 ($BILLION)
FIGURE 41. TYPEZERO TECHNOLOGIES, LLC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 42. TYPEZERO TECHNOLOGIES, LLC: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 43. BETA BIONICS, INC: NET SALES, 2021-2023 ($BILLION)
FIGURE 44. BETA BIONICS, INC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 45. BETA BIONICS, INC: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 46. INSULATE CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 47. INSULATE CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 48. INSULATE CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 49. DIABELOOP: NET SALES, 2021-2023 ($BILLION)
FIGURE 50. DIABELOOP: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 51. DIABELOOP: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 52. INREDA DIABETIC: NET SALES, 2021-2023 ($BILLION)
FIGURE 53. INREDA DIABETIC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 54. INREDA DIABETIC: REVENUE SHARE, BY REGION, 2023 (%)

Companies Mentioned

  • Medtronic plc
  • Bigfoot Biomedical, Inc.
  • Johnson & Johnson
  • Tandem Diabetes Care, Inc.
  • Pancreum, Inc
  • TypeZero Technologies, LLC
  • Beta Bionics, Inc
  • Insulate Corporation
  • Diabeloop
  • Inreda Diabetic

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Related Topics

Related Reports

Global Artificial Pancreas Device Systems Market - Product Image

Global Artificial Pancreas Device Systems Market

  • Report
  • 200 Pages
  • Global
From
Artificial Pancreas Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update - Product Image

Artificial Pancreas Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  • Report
  • 115 Pages
  • Global
From
Artificial Pancreas Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies - Product Image

Artificial Pancreas Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

  • Report
  • 121 Pages
  • Global
From
Global Artificial Pancreas Device Systems Market Report and Forecast 2024-2032 - Product Image

Global Artificial Pancreas Device Systems Market Report and Forecast 2024-2032

  • Report
  • 200 Pages
  • Global
From
Artificial Pancreas Device Systems - Global Strategic Business Report - Product Image

Artificial Pancreas Device Systems - Global Strategic Business Report

  • Report
  • 197 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.